Acurx presents Phase 2 results of ibezapolstat in C. difficile Infection
PremiumThe FlyAcurx presents Phase 2 results of ibezapolstat in C. difficile Infection
4M ago
Acurx reports results from meeting with FDA regarding ibezapolstat
Premium
The Fly
Acurx reports results from meeting with FDA regarding ibezapolstat
6M ago
Acurx presents ibezapolstat Phase 2 clinical trial results in CDI
Premium
The Fly
Acurx presents ibezapolstat Phase 2 clinical trial results in CDI
6M ago
Acurx announces results from ibezapolstat Phase 2b clinical trial
PremiumThe FlyAcurx announces results from ibezapolstat Phase 2b clinical trial
10M ago
Acurx price target raised by $1 at H.C. Wainwright, here’s why
Premium
The Fly
Acurx price target raised by $1 at H.C. Wainwright, here’s why
11M ago
Acurx price target raised to $14 from $13 at H.C. Wainwright
Premium
The Fly
Acurx price target raised to $14 from $13 at H.C. Wainwright
11M ago
Acurx price target lowered to $13 from $14 at H.C. Wainwright
PremiumThe FlyAcurx price target lowered to $13 from $14 at H.C. Wainwright
1y ago
Acurx reports Q2 EPS (28c), consensus (40c)
Premium
The Fly
Acurx reports Q2 EPS (28c), consensus (40c)
1y ago
Acurx files to sell 2.67M shares of common stock for holders
Premium
The Fly
Acurx files to sell 2.67M shares of common stock for holders
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100